SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-19-001277
Filing Date
2019-02-14
Accepted
2019-02-14 17:16:20
Documents
42
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_123118.htm 10-Q 387293
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 11562
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 10795
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 4715
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 4769
  Complete submission text file 0001387131-19-001277.txt   1678524

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20181231.xml EX-101.INS 195289
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20181231.xsd EX-101.SCH 19867
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20181231_cal.xml EX-101.CAL 27615
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20181231_def.xml EX-101.DEF 70529
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20181231_lab.xml EX-101.LAB 166300
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20181231_pre.xml EX-101.PRE 124784
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 19608287
SIC: 2834 Pharmaceutical Preparations